The changing roles and targets for animal models of schizophrenia

被引:89
作者
Kilts, CD [1 ]
机构
[1] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA
关键词
D O I
10.1016/S0006-3223(01)01286-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Unlike disorders of other fields of medicine (eg., diabetes, heart disease), schizophrenia has been only marginally impacted by the study of animal models. This gap reflects the incomplete understanding of the causes and mechanisms of schizophrenia and the resulting lack of defined targets for model development. However, prior attempts at modeling in animals the complex symptoms of schizophrenia hale given way to more promising component models. This review will address the evolving field of animal models of schizophrenia with a focus on models of errors in neurotransmission, and of psychophysiological deficits, with a concluding discussion of the present and future promise of genetic-based models. Evolving models based on the long-held conceptualization of schizophrenia as being based on errors in neurotransmission are discussed as regards the integration of newer findings implicating alterations in dopamine, glutamate and neurotensin function in the pathophysiology and pharmacotherapy of schizophrenia. The case for the snore recent conceptualization of schizophrenia as a core deficit in information processing and stimulus filtering is discussed. Animal behavioral paradigms that model psychophysiologic constructs of stimulus processing deficits related to schizophrenia include prepulse inhibition (PPI), a model of sensorimotor gating, or latent inhibition (LI), a model of salience learning. These models represent both better supported associations with schizophrenia and more productive targets and are providing important new it formation regarding the psychopharmacology of schizophrenia. Genetic models of schizophrenia are based on the demonstrated heritability of the disorder and snore recent pharmacogenetic findings for antipsychotic medications. Genetic-based animal models use behavioral or molecular genetic techniques to manipulate behaviors related to schizophrenia by altering the frequencies of related genes. The future development of increasingly, informative animal models of schizophrenia will be dependent on a snore complete understanding of schizophrenia, an integration of findings across animal models and refinements in the criteria used to assess model "validity" that better reflect the changing nature and roles of animal models of schizophrenia. (C) 2001 Society of Biological Psychiatry.
引用
收藏
页码:845 / 855
页数:11
相关论文
共 103 条
[1]   Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects [J].
Akil, M ;
Pierri, JN ;
Whitehead, RE ;
Edgar, CL ;
Mohila, C ;
Sampson, AR ;
Lewis, DA .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (10) :1580-1589
[2]   SYMPTOMS, SIGNS, AND DIAGNOSIS OF SCHIZOPHRENIA [J].
ANDREASEN, NC .
LANCET, 1995, 346 (8973) :477-481
[3]   Impaired auditory gating and P50 nonsuppression following traumatic brain injury [J].
Arciniegas, D ;
Olincy, A ;
Topkoff, J ;
McRae, K ;
Cawthra, E ;
Filley, CM ;
Reite, M ;
Adler, LE .
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2000, 12 (01) :77-85
[4]   Noise stress impairs prefrontal cortical cognitive function in monkeys - Evidence for a hyperdopaminergic mechanism [J].
Arnsten, AFT ;
Goldman-Rakic, PS .
ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (04) :362-368
[5]  
ARNT J, 1982, ACTA PHARMACOL TOX, V51, P321
[6]   ANTAGONISM OF PHENCYCLIDINE-INDUCED DEFICITS IN PREPULSE INHIBITION BY THE PUTATIVE ATYPICAL ANTIPSYCHOTIC OLANZAPINE [J].
BAKSHI, VP ;
GEYER, MA .
PSYCHOPHARMACOLOGY, 1995, 122 (02) :198-201
[7]   LATENT INHIBITION AND PSYCHOTIC PRONENESS IN NORMAL SUBJECTS [J].
BARUCH, I ;
HEMSLEY, DR ;
GRAY, JA .
PERSONALITY AND INDIVIDUAL DIFFERENCES, 1988, 9 (04) :777-783
[8]   DIFFERENTIAL PERFORMANCE OF ACUTE AND CHRONIC-SCHIZOPHRENICS IN A LATENT INHIBITION TASK [J].
BARUCH, I ;
HEMSLEY, DR ;
GRAY, JA .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1988, 176 (10) :598-606
[9]   Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain [J].
Benes, FM .
SCHIZOPHRENIA BULLETIN, 1998, 24 (02) :219-230
[10]   Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: Evidence from animal models of sensorimotor gating [J].
Binder, EB ;
Kinkead, B ;
Owens, MJ ;
Kilts, CD ;
Nemeroff, CB .
JOURNAL OF NEUROSCIENCE, 2001, 21 (02) :601-608